Features associated with treatment failure by 6 months
| Treatment failure (n=9 patients) | No treatment failure (n=11 patients) | |
| Number of patients with active disease at baseline (%) | 7 (77.8) | 4 (36.4) |
| Number of patients with bilateral disease (%) | 9 (100) | 4 (36.4) |
| Number of patients who required previous ocular steroid injections (%) | 6 (66.7) | 7 (63.6) |
| Mean duration of uveitis prior to adalimumab, in months (range) | 72.6 (17–204) | 100.5 (12–266) |
| Median duration of uveitis prior to adalimumab, in months (IQR) | 56 (27–79) | 67 (46–178) |
| Mean number of prior systemic agents used (range) | 3.7 (2–5) | 2.6 (0–4) |
| Median number of prior systemic agents used (IQR) | 4 (3–4) | 3 (2–4) |